Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial-Reference-Cited by-同舟云学术

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

Published:2013-09 Issue:10 Volume:14 Page:933-942
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cameron David,Brown Julia,Dent Rebecca,Jackisch Christian,Mackey John,Pivot Xavier,Steger Guenther G,Suter Thomas M,Toi Masakazu,Parmar Mahesh,Laeufle Rita,Im Young-Hyuck,Romieu Gilles,Harvey Vernon,Lipatov Oleg,Pienkowski Tadeusz,Cottu Paul,Chan Arlene,Im Seock-Ah,Hall Peter S,Bubuteishvili-Pacaud Lida,Henschel Volkmar,Deurloo Regula J,Pallaud Celine,Bell Richard

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007

2. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007

3. Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial;Brufsky;Breast Cancer Res Treat,2012

4. Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer;von Minckwitz;N Engl J Med,2012

5. Bevacizumab added to neoadjuvant chemotherapy for breast cancer;Bear;N Engl J Med,2012

Cited by 362 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

2. Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810;Journal of Clinical Oncology;2024-06-10

3. Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives;Expert Review of Anticancer Therapy;2024-03-21

4. Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer;BMC Cancer;2024-03-11

5. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study;Frontiers in Cell and Developmental Biology;2024-02-22